Interaction of polymicrobial biofilms with human immune cells

多种微生物生物膜与人体免疫细胞的相互作用

基本信息

  • 批准号:
    2089928
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Studentship
  • 财政年份:
    2018
  • 资助国家:
    英国
  • 起止时间:
    2018 至 无数据
  • 项目状态:
    已结题

项目摘要

Multidrug resistance is causing redundancy of entire classes of antibiotics and making the end of the "antibiotic era", in which common infections and minor injuries can kill, a real possibility. The ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumanii, Pseudomonas aeruginosa, and enterobacteriaceae) are resistant to the biocidal action of antibiotics and there is an urgent need for the development of new antimicrobial options underpinned by a better understanding of the pathogenicity of ESKAPE organisms.P. aeruginosa (PA) is a highly versatile environmental organism. PA flourishes in the hospital setting where it causes serious infections in immunocompromised and burn patients. PA infection is especially troublesome in Cystic Fibrosis (CF) patients where it is a major determinant of the irreversible loss of lung function and mortality. Breach of immune defences enables PA to cause intractable infections due to its intrinsic resistance to antibiotics and ability to form biofilms. Transition from planktonic to sessile growth and biofilm development are central to PA pathogenesis. There is an urgent need to better understand how the switch to a biofilm life style contributes to PA virulence and how immune cells detect and respond to these structures. PA biofilms consist of an extracellular matrix containing two main carbohydrate polymers, Psl and Pel. Our recent results show that three major carbohydrate-binding (lectin) receptors expressed by immune cells, DC-SIGN (CD209), the mannose receptor (MR, CD206) and Dectin-2, interact with PA biofilms. Binding is calcium-dependent, inhibited by relevant sugars, and observed in biofilms formed by PAO1 and clinical isolates. DC-SIGN, MR and Dectin-2 ligands within biofilms showed differential distribution. Human monocyte-derived dendritic cells (huDCs) incubated with wells containing Psl+/Pel+, Psl+/Pel- and Psl-/Pel+ biofilms alongside wells containing bacteria non capable of biofilm formation Psl-/Pel- selectively produce IL-1B (4 and 18 h) and IL-23 (only 4 h) in response to biofilm-containing wells, with biofilms containing more Psl tending to induce less IL 23. Further, specific blockage of lectin receptors in huDCs alters their response to PA biofilms. These results suggest that biofilms do not just provide an effective barrier against immune attack but could also modulate immune cell activation in the context of PA infection through engagement of lectin receptors. Many infections, such as pulmonary infections occurring in patients with CF, are polymicrobial in nature. Most children with CF are initially colonised with S. aureus in their airways. With time S. aureus is commonly replaced with PA, resulting in a period of co-infection. S. aureus can produce a multilayered biofilm embedded within a glycocalyx or slime layer. The glycocalix contains a polysaccharide antigen named polysaccharide intercellular antigen (PIA). PIA is composed of B-1,6-linked N-acetylglucosamine residues (80-85%) and an anionic fraction with a lower content of non-N-acetylated D-glucosaminyl residues that contains phosphate and ester-linked succinate (15-20%). No receptors for PIA have been described to date. We hypothesise that mixed biofilms formed by PA and S. aureus will display altered carbohydrate production leading to differential engagement of lectin receptors and differential activation of human immune cells. The specific aims of this project are (i) to investigate how PA and S. aureus mixed biofilms influence the activation of human immune cells (ii) and determine the contribution of lectin receptors to these responses.
多重耐药性正在导致整个抗生素类别的冗余,并使“抗生素时代”结束,在这个时代,普通感染和轻微伤害都可能导致死亡,这是一个真实的可能性。ESKAPE病原体(屎肠球菌、金黄色葡萄球菌、肺炎克雷伯氏菌、鲍曼不动杆菌、铜绿假单胞菌和肠杆菌科)对抗生素的杀菌作用具有抗性,并且迫切需要开发新的抗菌剂选择以更好地理解ESKAPE微生物的致病性为基础。PA在医院环境中传播,在免疫功能低下和烧伤患者中引起严重感染。PA感染在囊性纤维化(CF)患者中尤其麻烦,其中PA感染是肺功能不可逆丧失和死亡率的主要决定因素。由于PA对抗生素的内在抗性和形成生物膜的能力,免疫防御的破坏使PA能够引起难治性感染。从无张力到固着生长和生物膜发育的转变是PA发病机制的核心。迫切需要更好地了解生物膜生活方式的转变如何有助于PA毒力以及免疫细胞如何检测和响应这些结构。PA生物膜由含有两种主要碳水化合物聚合物Psl和Pel的细胞外基质组成。我们最近的研究结果表明,免疫细胞表达的三种主要的碳水化合物结合(凝集素)受体,DC-SIGN(CD 209),甘露糖受体(MR,CD 206)和Dectin-2,与PA生物膜相互作用。结合是钙依赖性的,受相关糖的抑制,并在PAO 1和临床分离株形成的生物膜中观察到。DC-SIGN、MR和Dectin-2配体在生物膜中的分布存在差异。与含有Psl+/Pel+、Psl+/Pel-和Psl-/Pel+生物膜的威尔斯孔以及含有不能形成生物膜的细菌Psl-/Pel-的威尔斯孔一起孵育的人单核细胞衍生的树突细胞(huDC)响应于含有生物膜的威尔斯孔选择性地产生IL-1B(4和18小时)和IL-23(仅4小时),其中含有更多Psl的生物膜倾向于诱导更少的IL 23。此外,huDC中凝集素受体的特异性阻断改变了它们对PA生物膜的响应。这些结果表明,生物膜不仅提供了对抗免疫攻击的有效屏障,而且还可以通过与凝集素受体的结合来调节PA感染背景下的免疫细胞活化。许多感染,如CF患者发生的肺部感染,本质上是多微生物感染。大多数患有CF的儿童最初被S.金黄色葡萄球菌时间S。金黄色葡萄球菌通常被PA替代,导致一段时间的合并感染。S.金黄色葡萄球菌可产生嵌入糖萼或粘液层内的多层生物膜。糖杯含有称为多糖细胞间抗原(PIA)的多糖抗原。PIA由B-1,6-连接的N-乙酰葡糖胺残基(80-85%)和含有磷酸盐和酯连接的琥珀酸盐的非N-乙酰化D-葡糖胺基残基含量较低的阴离子级分(15-20%)组成。迄今为止还没有描述PIA的受体。我们推测PA和S.金黄色葡萄球菌将显示改变的碳水化合物产生,导致凝集素受体的差异接合和人免疫细胞的差异活化。本项目的具体目标是:(i)研究PA和S。金黄色葡萄球菌混合生物膜影响人免疫细胞的活化(II)并决定凝集素受体对这些应答的贡献。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

其他文献

吉治仁志 他: "トランスジェニックマウスによるTIMP-1の線維化促進機序"最新医学. 55. 1781-1787 (2000)
Hitoshi Yoshiji 等:“转基因小鼠中 TIMP-1 的促纤维化机制”现代医学 55. 1781-1787 (2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
LiDAR Implementations for Autonomous Vehicle Applications
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
生命分子工学・海洋生命工学研究室
生物分子工程/海洋生物技术实验室
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
吉治仁志 他: "イラスト医学&サイエンスシリーズ血管の分子医学"羊土社(渋谷正史編). 125 (2000)
Hitoshi Yoshiji 等人:“血管医学与科学系列分子医学图解”Yodosha(涉谷正志编辑)125(2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Effect of manidipine hydrochloride,a calcium antagonist,on isoproterenol-induced left ventricular hypertrophy: "Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,K.,Teragaki,M.,Iwao,H.and Yoshikawa,J." Jpn Circ J. 62(1). 47-52 (1998)
钙拮抗剂盐酸马尼地平对异丙肾上腺素引起的左心室肥厚的影响:“Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:

的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('', 18)}}的其他基金

An implantable biosensor microsystem for real-time measurement of circulating biomarkers
用于实时测量循环生物标志物的植入式生物传感器微系统
  • 批准号:
    2901954
  • 财政年份:
    2028
  • 资助金额:
    --
  • 项目类别:
    Studentship
Exploiting the polysaccharide breakdown capacity of the human gut microbiome to develop environmentally sustainable dishwashing solutions
利用人类肠道微生物群的多糖分解能力来开发环境可持续的洗碗解决方案
  • 批准号:
    2896097
  • 财政年份:
    2027
  • 资助金额:
    --
  • 项目类别:
    Studentship
A Robot that Swims Through Granular Materials
可以在颗粒材料中游动的机器人
  • 批准号:
    2780268
  • 财政年份:
    2027
  • 资助金额:
    --
  • 项目类别:
    Studentship
Likelihood and impact of severe space weather events on the resilience of nuclear power and safeguards monitoring.
严重空间天气事件对核电和保障监督的恢复力的可能性和影响。
  • 批准号:
    2908918
  • 财政年份:
    2027
  • 资助金额:
    --
  • 项目类别:
    Studentship
Proton, alpha and gamma irradiation assisted stress corrosion cracking: understanding the fuel-stainless steel interface
质子、α 和 γ 辐照辅助应力腐蚀开裂:了解燃料-不锈钢界面
  • 批准号:
    2908693
  • 财政年份:
    2027
  • 资助金额:
    --
  • 项目类别:
    Studentship
Field Assisted Sintering of Nuclear Fuel Simulants
核燃料模拟物的现场辅助烧结
  • 批准号:
    2908917
  • 财政年份:
    2027
  • 资助金额:
    --
  • 项目类别:
    Studentship
Assessment of new fatigue capable titanium alloys for aerospace applications
评估用于航空航天应用的新型抗疲劳钛合金
  • 批准号:
    2879438
  • 财政年份:
    2027
  • 资助金额:
    --
  • 项目类别:
    Studentship
Developing a 3D printed skin model using a Dextran - Collagen hydrogel to analyse the cellular and epigenetic effects of interleukin-17 inhibitors in
使用右旋糖酐-胶原蛋白水凝胶开发 3D 打印皮肤模型,以分析白细胞介素 17 抑制剂的细胞和表观遗传效应
  • 批准号:
    2890513
  • 财政年份:
    2027
  • 资助金额:
    --
  • 项目类别:
    Studentship
CDT year 1 so TBC in Oct 2024
CDT 第 1 年,预计 2024 年 10 月
  • 批准号:
    2879865
  • 财政年份:
    2027
  • 资助金额:
    --
  • 项目类别:
    Studentship
Understanding the interplay between the gut microbiome, behavior and urbanisation in wild birds
了解野生鸟类肠道微生物组、行为和城市化之间的相互作用
  • 批准号:
    2876993
  • 财政年份:
    2027
  • 资助金额:
    --
  • 项目类别:
    Studentship

相似海外基金

Microenvironmental characterization and manipulation to prevent secondary caries
预防继发龋的微环境特征和操作
  • 批准号:
    10814030
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Development and characterization of anti-P. gingivalis peptides
抗 P 的开发和表征。
  • 批准号:
    10625080
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Bacterial Adhesion Inhibition and Biofilm Disruption by Adaptive Piezoelectric Biomaterial
自适应压电生物材料抑制细菌粘附和破坏生物膜
  • 批准号:
    10668030
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Harnessing polymicrobial interactions in the catheterized urinary tract to identify novel inhibitors of Proteus mirabilis urease activity
利用插管尿路中的多种微生物相互作用来鉴定奇异变形杆菌尿素酶活性的新型抑制剂
  • 批准号:
    10678389
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Durable fluid-like surface for sustainable biofilm inhibition
耐用的流体状表面可实现可持续的生物膜抑制
  • 批准号:
    10646770
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Small Scale Robotics for Automated Dental Biofilm Theranostics
用于自动化牙科生物膜治疗的小型机器人
  • 批准号:
    10658028
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
A novel electric current-based treatment system for chronic wound biofilm infections
一种新型的基于电流的慢性伤口生物膜感染治疗系统
  • 批准号:
    10720191
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Caries resistance mechanisms in high-risk Indigenous children
高危原住民儿童的防龋机制
  • 批准号:
    10639704
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
A New Class of Chemically Modified Small RNA Inhibitors against Fusobacterium nucleatum
一类新型化学修饰小 RNA 抑制剂,抗具核梭杆菌
  • 批准号:
    10875055
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
A theranostic ultrasound approach to improve chronic wound treatment using phase-change contrast agents
使用相变造影剂改善慢性伤口治疗的超声治疗方法
  • 批准号:
    10733848
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了